Fanouriakis A, Tziolos N, Bertsias G, Boumpas D. Update οn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14–21.

Article  PubMed  Google Scholar 

Vilar MJ, Sato EI. Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). Lupus. 2002;11(8):528–32.

Article  PubMed  Google Scholar 

Klumb E, Scheinberg M, Souza V, Xavier R, Azevedo V, McElwee E, et al. The landscape of systemic lupus erythematosus in Brazil: an expert panel review and recommendations. Lupus 2021;30:1684–95.

Article  PubMed  PubMed Central  Google Scholar 

Klumb EM, Silva CA, Lanna CC, Sato EI, Borba EF, Brenol JC, et al. Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis. Rev Bras Reumatol 2015;55:1–21.

Article  PubMed  Google Scholar 

Moberg J, Oxman A, Rosenbaum S, Schünemann H, Guyatt G, Flottorp S, et al. The GRADE Evidence to Decision (EtD) framework for health system and public health decisions. Health Res Policy Syst 2018;16:45.

Article  PubMed  PubMed Central  Google Scholar 

Gatto M, Zen M, Iaccarino L, Doria A. New therapeutic strategies in systemic lupus erythematosus management. Nat Rev Rheumatol. 2019;15(1):30–48.

Article  CAS  PubMed  Google Scholar 

Gladman D, Ibañez D, Ruiz I, Urowitz M. Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort study. J Rheumatol. 2013;40(5):630–33.

Article  PubMed  Google Scholar 

Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) 2012;64:797–808.

Article  PubMed  Google Scholar 

Christopher-Stine L, Siedner M, Lin J, Haas M, Parekh H, Petri M, et al. Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol 2007;34:332–35.

PubMed  Google Scholar 

Zabaleta-Lanz M, Muñoz L, Tapanes F, Vargas-Arenas R, Daboin I, Barrios Y, et al. Further description of early clinically silent lupus nephritis. Lupus 2006;15:845–51.

Article  CAS  PubMed  Google Scholar 

Medina-Rosas J, Yap K, Anderson M, Su J, Touma Z. Utility of urinary protein-creatinine ratio and protein content in a 24-hour urine collection in systemic lupus erythematosus: a systematic review and meta-analysis. Arthritis Care Res. 2016;68(9):1310–19.

Article  CAS  Google Scholar 

Choi I, Park J, Lee E, Song Y, Lee E. Random spot urine protein to creatinine ratio is a reliable measure of proteinuria in lupus nephritis in Koreans. Clin Exp Rheumatol. 2013;31(4):584–88.

PubMed  Google Scholar 

Marques G, Cotovio P, Ferrer F, Silva C, Botelho C, Lopes K, et al. Random spot urine protein/creatinine ratio: a reliable method for monitoring lupus nephritis? Clin Kidney J 2013;6:590–94.

Article  Google Scholar 

McCarty G, Rice J, Bembe M, Pisetsky D. Independent expression of autoantibodies in systemic lupus erythematosus. J Rheumatol. 1982;9(5):691–95.

CAS  PubMed  Google Scholar 

Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, et al. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis 2009;68:234–37.

Article  CAS  PubMed  Google Scholar 

Orbai A, Truedsson L, Sturfelt G, Nived O, Fang H, Alarcón G, et al. Anti-C1q antibodies in systemic lupus erythematosus. Lupus 2015;24:42–49.

Article  CAS  PubMed  Google Scholar 

Bootsma H, Spronk P, Derksen R, de Boer G, Wolters-Dicke H, Hermans J, et al. Prevention of relapses in systemic lupus erythematosus. Lancet (London, England) 1995;345:1595–99.

Article  CAS  PubMed  Google Scholar 

van Vollenhoven RF, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrom K, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 2014;73:958–67.

Article  PubMed  Google Scholar 

Hung W, Chen Y, Lan J, Chen H, Chen Y, Chen D, et al. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis. Lupus 2011;20:1404–10.

Article  CAS  PubMed  Google Scholar 

Do Nascimento AP, Dos Santos Trindade Viana V, de Abreu Testagrossa L, Leon EP, Borba EF, Barros RT, et al. Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis. Arthritis Rheum 2006;54:1568–72.

Article  CAS  PubMed  Google Scholar 

de Macedo PA, Borba EF, Viana VD, Leon EP, de Abreu Testagrossa L, Barros RT, et al. Antibodies to ribosomal P proteins in lupus nephritis: a surrogate marker for a better renal survival? Autoimmun Rev 2011;10:126–30.

Article  PubMed  Google Scholar 

Wang S, Shang J, Xiao J, Zhao Z. Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody. Ren Fail. 2020;42(1):244–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turner-Stokes T, Wilson H, Morreale M, Nunes A, Cairns T, Cook H, et al. Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy. Kidney Int 2017;92:1223–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenkranz A, Tesar V. Lupus nephritis and ANCA-associated vasculitis: towards precision medicine? Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. Nephrol Dial Transplant. 2021;36(Suppl 2):37–43.

Article  PubMed  Google Scholar 

Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241–50.

Article  PubMed  Google Scholar 

Bajema I, Wilhelmus S, Alpers C, Bruijn J, Colvin R, Cook H, et al. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 2018;93:789–96.

Article  PubMed  Google Scholar 

Austin H, Muenz L, Joyce K, Antonovych T, Balow J. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 1984;25(4):689–95.

Article  PubMed  Google Scholar 

Parodis I, Tamirou F, Houssiau F. Prediction of prognosis and renal outcome in lupus nephritis. Lupus Sci Med. 2020;7(1):e000389.

Article  PubMed  PubMed Central  Google Scholar 

Fanouriakis A, Kostopoulou M, Cheema K, Anders H, Aringer M, Bajema I, et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis 2020;79:713–23.

Article  CAS  PubMed  Google Scholar 

Parikh S, Alvarado A, Malvar A, Rovin B. The kidney biopsy in lupus nephritis: past, present, and future. Semin Nephrol. 2015;35(5):465–77.

Article  PubMed  Google Scholar 

Anders H, Saxena R, Zhao M, Parodis I, Salmon J, Mohan C. Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):7.

Article  PubMed  Google Scholar 

Mejia-Vilet J, Malvar A, Arazi A, Rovin B. The lupus nephritis management renaissance. Kidney Int. 2022;101(2):242–55.

Article  CAS  PubMed  Google Scholar 

KDIGO. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4S):S1–S276.